|
CHMP2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9247000004885E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.59869999999596E-06 |
| Normal-vs-Stage2 |
1.604370E-04 |
| Normal-vs-Stage3 |
8.10300000000375E-05 |
| Normal-vs-Stage4 |
2.028800E-04 |
| Stage1-vs-Stage2 |
1.170210E-01 |
| Stage1-vs-Stage3 |
7.250800E-01 |
| Stage1-vs-Stage4 |
8.573000E-01 |
| Stage2-vs-Stage3 |
1.724790E-01 |
| Stage2-vs-Stage4 |
1.811620E-01 |
| Stage3-vs-Stage4 |
8.978600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.37589999999111E-06 |
| Normal-vs-AfricanAmerican |
3.244800E-03 |
| Normal-vs-Asian |
4.439300E-04 |
| Caucasian-vs-AfricanAmerican |
9.659800E-01 |
| Caucasian-vs-Asian |
5.628800E-01 |
| AfricanAmerican-vs-Asian |
7.069400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18969999995944E-06 |
| Normal-vs-Female |
1.23610000002383E-06 |
| Male-vs-Female |
2.649600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57986000000054E-05 |
| Normal-vs-Age(41-60Yrs) |
4.40609999999841E-05 |
| Normal-vs-Age(61-80Yrs) |
2.625000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.329150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.071800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.783200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.354000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.102800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.865600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.057800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.882400E-01 |
| Classical-VS-Follicular |
2.061900E-03 |
| Classical-VS-Other |
5.221800E-01 |
| Classical-VS-Normal |
1.91363999999528E-05 |
| Tall-VS-Follicular |
8.716900E-03 |
| Tall-VS-Other |
4.551200E-01 |
| Tall-VS-Normal |
8.354200E-02 |
| Follicular-VS-Other |
7.295800E-01 |
| Follicular-VS-Normal |
1.6066999952713E-08 |
| Other-VS-Normal |
2.148000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08509999985351E-07 |
| Normal-vs-N1 |
4.223900E-04 |
| N0-vs-N1 |
7.488800E-01 |
|
|
